MSB 0.91% $1.11 mesoblast limited

Maybe not MSB but as below the need to meet strict protocols may...

  1. 220 Posts.
    Maybe not MSB but as below the need to meet strict protocols may help explain the delay! Why MSB can't simply say this though is a mystery.

    Important Considerations

    If you are a patient or physician referring an interested patient into a research protocol there are a few important considerations:
    •The primary concern for any investigation must be the safety of all participants.
    •The Stem Cell Center conducts clinical trials in strict accordance with protocols which have been approved by institutional governing agencies including the FDA, and St. Luke’s Episcopal Hospital Institutional Review Board.
    •The Stem Cell Center is dedicated to conducting relevant, well designed, and safe clinical studies. The protocols, therefore, are very strict and no exceptions can be made regarding the criteria that are used to include or exclude patients.
    •Patients are not given monetary compensation for enrollment into the different studies. Once enrolled in the trial, patients are not charged for any therapy or monitoring that is directly related to the research.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.